ArticleOncology letters2013

A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: Hematological and non-hematological toxicity profiles.

Bengt Sorbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.